Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption.

1. Naringin, a grapefruit constituent interacts with many medications including caffeine, a popular weight loss supplement. The purpose of the current study was to identify changes in caffeine pharmacokinetics, resting energy expenditure (REE), oxygen consumption (VO(2)) and respiratory exchange ratio (RER) after an acute dosage of caffeine and naringin. 2. Using a double-blinded, counterbalanced design, REE, VO(2), and RER were measured before and systematically for 8 h after a single dosage of caffeine (CAF, 200 mg) with and without naringin (100 mg (CN100) or 200 mg (CN200)) in 10 apparently healthy individuals. A standardized meal was provided following 240-minute measurements (400 kcals; 35 g carbohydrate; 27 g protein; 7 g fat). 3. Caffeine, CN100, CN200 did not alter VO(2) or VO(2) area under the curve (137 301 +/- 8318, 139 729 +/- 9300, 134 297 +/- 8318, mL/480 min). Resting energy expenditure (k/cals) was 10.0 +/- 1.4% higher with CAF versus CN200 (6.0 +/- 1.4%) and CN100 (6 +/- 1.5%) at 240 min (P = 0.07) which was then negated following a standardized meal. Percent change in RER from pre to 240 min and pre to 480 min was not different between the CAF, CN100, or CN200 (-0.2 +/- 1.7%, 1.7 +/- 1.7%, -2.8 +/- 1.9%). 4. Although caffeine alone suggests a trend of increased REE, the results of the present study indicate that concurrent consumption of caffeine with naringin in acute dosages does not affect RER, VO(2), and prevents the increase of REE in adult humans. The results suggest that the interaction of grapefruit juice and caffeine may be due to constituents of grapefruit juice other than naringin or in addition to naringin.

Effect of protein supplementation during a 6-month strength and conditioning program on areal and volumetric bone parameters.

BACKGROUND: Skeletal loading and proper nutrition are necessary for optimal bone health. The appropriate amount of dietary protein to maximize skeletal health, however, is under constant debate. OBJECTIVE: To determine if 6 months of protein supplementation in conjunction with a strength and conditioning training program improves areal and volumetric bone mineral density (BMD). DESIGN: Fifty-two apparently healthy males and females ages 18-25 years were randomized to protein supplement (PRO, Myoplex, EAS, Inc. Golden CO) containing 280 kcal, 42 g protein, 21 g carbohydrate, and 1.5 g fat) or calorically equivalent carbohydrate control (CS). All subjects participated in a 5 sessions/week strength and conditioning program. Volumetric and areal BMD measurements were made by peripheral quantitative computed tomography (pQCT) of the tibia and whole body DXA. pSSI a measure of torsional bone strength, based on structural and material properties was obtained by pQCT. RESULTS: Measurements at the 20% tibia by pQCT revealed that overall there were significant increases in cortical vBMD (4.3 +/- 1.3 mg/cm(3)), cortical area (1.9 +/- 0.6 cm(2)), cortical thickness (0.05 +/- 0.02 mm) and pSSI (67 +/- 24 mm(3)), and a decrease in endosteal circumference (- 0.5 +/- 0.2 mm) over the intervention period (all, P < 0.05). None of the changes in DXA measures were found to differ by group or sex, there was a trend for a greater increase in whole body BMC among the carbohydrate compared to protein supplemented group and a greater increase among males (16 +/- 8 g) compared to females (-9 +/- 9 g) (P = 0.06). CONCLUSIONS: The results of this study indicate that the consumption of additional protein does not improve measurements of vBMD or bone size during a 6-month strength and conditioning program. Longer duration studies may be necessary to determine the influence of increased dietary protein on bone in young adults. Males and females may have different bone responses to increased protein intake while participating in a strength and conditioning program.